Purchase Order 75N90019P00660

This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $2,387.15 firm fixed-price purchase order is for the supply of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as the radiopharmaceutical therapy Xofigo (radium-223 dichloride) for prostate cancer treatment. These critical medical isotopes and radiopharmaceuticals are used in nuclear medicine, oncology, and diagnostic imaging services at the NIH Clinical Center. The contract has an ultimate completion date of September 30, 2019 and does not have a set-aside designation, reflecting Cardinal Health 414's status as a large, established supplier capable of meeting complex federal healthcare requirements. This award is part of Cardinal Health's broader portfolio of federal contracts, including multiple Indefinite Delivery Vehicle (IDV) contracts with the Department of Veterans Affairs (VA) and the Defense Health Agency (DHA) for the ongoing supply of radiopharmaceuticals to VA medical facilities and military treatment facilities nationwide.